Skip to main content
Publications
Matharu M, Pascual J, Nisson Remahl I, Straube A, Lum A, Davar G, Odom D, Bennett L, Proctor C, Gutierrez L, Andrews E, Johannes C. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. Cephalalgia. 2017 Dec;37(14):1384-97. doi: 10.1177/0333102417724150
Bommireddy R, Pack CD, Bozeman EN, Patel JM, Vartebedian VF, Munoz LE, Shafizadeh Y, Menon AP, Lakshmanan R, Reddy SJC, Selvaraj P. Membrane-based immunotherapy with immune checkpoint blockade antibodies confers protection against metastatic breast cancer. Poster presented at the Immunology 2017 Meeting; May 12, 2017. Washington, DC. [abstract] J Immunol. 2017 May 1; 198(1_Supplement):120.8. doi: 10.4049/jimmunol.198.Supp.120.8
Munoz LE, Bommireddy R, Margaroli C, Shafizadeh Y, Bozeman EN, Menon AP, Kumar J, Lakshmanan R, Selvaraj P. HER-2+ breast cancer cells expressing GPI-anchored cytokines induce long lasting antitumor memory response. Poster presented at the Immunology 2017 Meeting; May 12, 2017. Washington, DC. [abstract] J Immunol. 2017 May 1; 198(1_Supplement):79.28. Previously presented at the International Congress of Immunology (ICI) 2016. doi: 10.4049/jimmunol.198.Supp.79.28
Matharu M, Pascual J, Nilsson Remahl L, Straube A, Johannes C, Odom D, Gutierrez L, Andrews E, Lum A. Interim analysis of the real-world utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in an observational study in the European Union. Poster presented at the International Headache Conference; May 14, 2015. Valencia, Spain. [abstract] Cephalalgia. 2015; 35(6S):39.